bupropion hydrochloride

Generic: bupropion hydrochloride

Labeler: a-s medication solutions
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name bupropion hydrochloride
Generic Name bupropion hydrochloride
Labeler a-s medication solutions
Dosage Form TABLET, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

bupropion hydrochloride 150 mg/1

Manufacturer
A-S Medication Solutions

Identifiers & Regulatory

Product NDC 50090-5163
Product ID 50090-5163_6f3ebf11-0131-4add-860d-3c3fe243d5ee
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA210497
Listing Expiration 2026-12-31
Marketing Start 2018-11-08

Pharmacologic Class

Classes
aminoketone [epc] dopamine uptake inhibitors [moa] increased dopamine activity [pe] increased norepinephrine activity [pe] norepinephrine uptake inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 500905163
Hyphenated Format 50090-5163

Supplemental Identifiers

RxCUI
993541
UNII
ZG7E5POY8O

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name bupropion hydrochloride (source: ndc)
Generic Name bupropion hydrochloride (source: ndc)
Application Number ANDA210497 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 150 mg/1
source: ndc
Packaging
  • 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-5163-0)
  • 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-5163-1)
  • 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-5163-2)
source: ndc

Packages (3)

50090-5163-0 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-5163-0) 50090-5163-1 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-5163-1) 50090-5163-2 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-5163-2)

Ingredients (1)

bupropion hydrochloride (150 mg/1)

Linked Drug Pages (1)

BUPROPION HYDROCHLORIDE ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "6f3ebf11-0131-4add-860d-3c3fe243d5ee", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993541"], "spl_set_id": ["77b78d35-40f5-4713-8468-aa09a6c2925d"], "manufacturer_name": ["A-S Medication Solutions"]}, "finished": true, "packaging": [{"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-5163-0)", "package_ndc": "50090-5163-0", "marketing_start_date": "20200923"}, {"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-5163-1)", "package_ndc": "50090-5163-1", "marketing_start_date": "20200923"}, {"sample": false, "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-5163-2)", "package_ndc": "50090-5163-2", "marketing_start_date": "20200923"}], "brand_name": "BUPROPION HYDROCHLORIDE", "product_id": "50090-5163_6f3ebf11-0131-4add-860d-3c3fe243d5ee", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "50090-5163", "generic_name": "BUPROPION HYDROCHLORIDE", "labeler_name": "A-S Medication Solutions", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BUPROPION HYDROCHLORIDE", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA210497", "marketing_category": "ANDA", "marketing_start_date": "20181108", "listing_expiration_date": "20261231"}